Dennert G, De Rose M, Allen R S
Eur J Immunol. 1977 Jul;7(7):487-92. doi: 10.1002/eji.1830070716.
Thymus-derived lymphocytes (T cells) selected for reactivity to strong histocompatibility antigens over a period of one to twelve months in vitro were tested for their ability to cooperate with bone marrow-derived lymphocytes (B cells) for a humoral response. If cultured with normal syngeneic or allogeneic spleen cells and sheep erythrocytes (SRBC) as immunogen, inhibition of the anti-SRBC response was observed. Similarly, in T cell-free spleen cells the alloreactive T cells did not stimulate a humoral response, indicating that they cannot exert cooperative activity on B cells. Since it was possible that the alloreactive T cells may cooperate with B cells in a humoral response to immunogens carrying histocompatibility antigens, hapten-coupled tumor cells were also used as immunogen. Though it is demonstrated that the alloreactive T cells do recognize the tumor cell immunogen, no stimulation of the B cells for a humoral response against the tumor cell is observed. This result, as well as the finding that the antigenic requirements for T helper cell priming and cell proliferation of the alloreactive T cells are different, suggests that these alloreactive T cells and helper T cells belong to different T cell subsets.
在体外培养一到十二个月,选择对强组织相容性抗原有反应性的胸腺来源淋巴细胞(T细胞),检测它们与骨髓来源淋巴细胞(B细胞)协同产生体液免疫反应的能力。如果将其与正常同基因或异基因脾细胞以及作为免疫原的绵羊红细胞(SRBC)一起培养,会观察到抗SRBC反应受到抑制。同样,在无T细胞的脾细胞中,同种反应性T细胞不会刺激体液免疫反应,这表明它们不能对B细胞发挥协同活性。由于同种反应性T细胞有可能在对携带组织相容性抗原的免疫原的体液免疫反应中与B细胞协同,因此也使用半抗原偶联的肿瘤细胞作为免疫原。尽管已证明同种反应性T细胞确实能识别肿瘤细胞免疫原,但未观察到B细胞针对肿瘤细胞产生体液免疫反应的刺激。这一结果,以及同种反应性T细胞的T辅助细胞致敏和细胞增殖的抗原需求不同这一发现,表明这些同种反应性T细胞和辅助性T细胞属于不同的T细胞亚群。